Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
NMPA:10
Drug Approvals
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20253014
- Approval Date
- Jan 2, 2025
NMPA
Galantamine Hydrobromide Orally Disintegrating Tablets
- Product Name
- 氢溴酸加兰他敏口腔崩解片
- Approval Number
- 国药准字H20140015
- Approval Date
- May 9, 2023
NMPA
Metoprolol Succinate Sustained-Release Tablets
- Product Name
- 琥珀酸美托洛尔缓释片
- Approval Number
- 国药准字H20213593
- Approval Date
- Jul 20, 2021
NMPA
Metoprolol Succinate Sustained-Release Tablets
- Product Name
- 琥珀酸美托洛尔缓释片
- Approval Number
- 国药准字H20213592
- Approval Date
- Jul 20, 2021
NMPA
Indapamide Sustained Release Tablets
- Product Name
- 吲达帕胺缓释片
- Approval Number
- 国药准字H20213537
- Approval Date
- Jun 22, 2021
NMPA
Isosorbide Mononitrate Sustained-release Capsules
- Product Name
- 单硝酸异山梨酯缓释胶囊
- Approval Number
- 国药准字H20203673
- Approval Date
- Dec 11, 2020
NMPA
Memantine Hydrochloride Tablets
- Product Name
- 盐酸美金刚片
- Approval Number
- 国药准字H20203555
- Approval Date
- Nov 4, 2020
NMPA
Clinical Trials
No trials found
News
No news found